About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Comedian Gabriel Iglesias shared his experience with Ozempic, revealing that he quit the medication after five months and quickly regained 20 lbs.

Researchers found that GLP-1 medicines caused weight loss mainly through fat reduction, with only modest decreases in absolute muscle mass and no disproportionate loss of muscle function. In mice, ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Fact checked by Jennifer Klump Key Takeaways A phase 2 clinical trial found that combining semaglutide with the antibody ...

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...

A 2026 consumer research report examining LipoJaro's metabolic support claims, the viral "jello recipe gelatin trick" weight loss discussion, ingredient research context, and what consumers ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

Planning for major weight loss may soon become an easier pill − or balloon − to swallow. As manufacturers ramp up for a GLP-1 legal battle and every food brand seems to be releasing new protein-packed ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...